Attached files
| file | filename |
|---|---|
| EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - ENDOLOGIX INC /DE/ | elgx-ex321_20191231x10k.htm |
| EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - ENDOLOGIX INC /DE/ | elgx-ex312_20191231x10k.htm |
| EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - ENDOLOGIX INC /DE/ | elgx-ex311_20191231x10k.htm |
| EX-23.1 - CONSENT OF INDEPENDENT REGISTERED ACCOUNTING FIRM (KPMG LLP) - ENDOLOGIX INC /DE/ | elgx-ex231_consentofindepe.htm |
| EX-21.1 - LIST OF SUBSIDIARIES - ENDOLOGIX INC /DE/ | elgx-ex211listofsubsidiari.htm |
| EX-10.3 - INDUCEMENT STOCK INCENTIVE PLAN - ENDOLOGIX INC /DE/ | elgx-ex1032017inducementst.htm |
| EX-4.1.2 - DESCRIPTION OF ENDOLOGIX, INC. CAPITAL STOCK - ENDOLOGIX INC /DE/ | elgx-ex412descriptionofend.htm |
| 10-K - 10-K - ENDOLOGIX INC /DE/ | elgx-20191231x10k.htm |
Exhibit 32.2
CERTIFICATION
In connection with the Annual Report of Endologix, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Vaseem Mahboob, Chief Financial Officer of the Company, certify, pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 (15 U.S.C. 78m or 780(d)) and 18 U.S.C. Section 1350, that to the best of my knowledge:
(1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ VASEEM MAHBOOB |
Vaseem Mahboob |
Chief Financial Officer |
This certification accompanies this Report pursuant to Rule 13a-14(b) or Rule 15d-14(b) under the Securities Exchange Act of 1934 and 18 U.S.C. Section 1350 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934.
Date: March 11, 2020